ImCheck Therapeutics to be acquired by pharmaceutical company Ipsen for a total potential consideration up to €1 billion
12 October 2025
12 October 2025
Total investments received (USD): N/A
Round value (USD): 1.17b
Company: ImCheck Therapeutics
Related deals
Adcytherix raised €105m in Series A from Andera Partners, Angelini Ventures, Kurma Partners, Surveyor Capital, aMoon, Pontifax, DawnBiopharma, RA Capital.
Investments
03 October 2025
Belgium
Netherlands
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Portugal
Spain